Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value ($000): $130,625 (100.0% shares, 0.0% debt)

Holdings (21)

LGND LIGAND PHARMACEUTICALS 24.8%

Value ($000) $32,431 Shares 326,100 Est. Cost $64.80 Unrealized -12.0%

— AMRYT PHARMA LTD - SPNR ADR 15.4%

Value ($000) $20,057 Shares 1,416,483 Est. Cost $13.19 Unrealized —

DMAC DIAMEDICA THERAPEUTICS INC 7.4%

Value ($000) $9,633 Shares 950,000 Est. Cost $4.62 Unrealized +18.5%

— AYTU BIOSCIENCE INC 6.4%

Value ($000) $8,365 Shares 1,398,776 Est. Cost $5.98 Unrealized —

— APOLLO ENDOSURGERY INC 6.1%

Value ($000) $7,909 Shares 2,326,165 Est. Cost $3.98 Unrealized —

— CTI BIOPHARMA CORP 5.1%

Value ($000) $6,614 Shares 2,054,000 Est. Cost $2.16 Unrealized —

— IVERIC BIO INC 4.2%

Value ($000) $5,528 Shares 800,000 Est. Cost $1.52 Unrealized —

XOMA XOMA CORP 4.2%

Value ($000) $5,478 Shares 124,130 Est. Cost $14.24 Unrealized +111.7%

— CATALYST BIOSCIENCES INC 4.0%

Value ($000) $5,265 Shares 834,449 Est. Cost $4.61 Unrealized —

SCYX SCYNEXIS INC 4.0%

Value ($000) $5,240 Shares 685,000 Est. Cost $5.86 Unrealized 0.0%

— ADAMAS PHARMACEUTICALS INC 2.7%

Value ($000) $3,501 Shares 808,431 Est. Cost $4.72 Unrealized —

— STRONGBRIDGE BIOPHARMA PLC 2.5%

Value ($000) $3,281 Shares 1,350,000 Est. Cost $2.10 Unrealized —

— GAMIDA CELL LTD 2.4%

Value ($000) $3,184 Shares 379,470 Est. Cost $8.39 Unrealized —

— CHIASMA INC 2.4%

Value ($000) $3,138 Shares 721,307 Est. Cost $4.33 Unrealized —

— NEOS THERAPEUTICS INC 2.4%

Value ($000) $3,100 Shares 4,962,657 Est. Cost $1.66 Unrealized —

— NOVUS THERAPEUTICS INC 2.0%

Value ($000) $2,577 Shares 167,333 Est. Cost $15.40 Unrealized —

— YUMANITY THERAPEUTICS INC 1.4%

Value ($000) $1,850 Shares 108,847 Est. Cost $17.00 Unrealized —

— AFFIMED NV 1.0%

Value ($000) $1,277 Shares 219,340 Est. Cost $3.39 Unrealized —

— VISTAGEN THERAPEUTICS INC 0.7%

Value ($000) $970 Shares 500,000 Est. Cost $1.94 Unrealized —

— APTEVO THERAPEUTICS INC 0.5%

Value ($000) $670 Shares 18,280 Est. Cost $36.65 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 0.4%

Value ($000) $557 Shares 188,703 Est. Cost $5.80 Unrealized -47.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS	326,100	$32,431	24.8%	$64.80	-12.0%	COM NEW	53220K504
—	AMRYT PHARMA LTD - SPNR ADR	1,416,483	$20,057	15.4%	$13.19	—	SPONSORED ADS	03217L106
DMAC	DIAMEDICA THERAPEUTICS INC	950,000	$9,633	7.4%	$4.62	+18.5%	COM NEW	25253X207
—	AYTU BIOSCIENCE INC	1,398,776	$8,365	6.4%	$5.98	—	COM	054754874
—	APOLLO ENDOSURGERY INC	2,326,165	$7,909	6.1%	$3.98	—	COM	03767D108
—	CTI BIOPHARMA CORP	2,054,000	$6,614	5.1%	$2.16	—	COM	12648L601
—	IVERIC BIO INC	800,000	$5,528	4.2%	$1.52	—	COM	46583P102
XOMA	XOMA CORP	124,130	$5,478	4.2%	$14.24	+111.7%	COM NEW	98419J206
—	CATALYST BIOSCIENCES INC	834,449	$5,265	4.0%	$4.61	—	COM NEW	14888D208
SCYX	SCYNEXIS INC	685,000	$5,240	4.0%	$5.86	0.0%	COM NEW	811292200
—	ADAMAS PHARMACEUTICALS INC	808,431	$3,501	2.7%	$4.72	—	COM	00548A106
—	STRONGBRIDGE BIOPHARMA PLC	1,350,000	$3,281	2.5%	$2.10	—	SHS USD	G85347105
—	GAMIDA CELL LTD	379,470	$3,184	2.4%	$8.39	—	SHS	M47364100
—	CHIASMA INC	721,307	$3,138	2.4%	$4.33	—	COM	16706W102
—	NEOS THERAPEUTICS INC	4,962,657	$3,100	2.4%	$1.66	—	COM	64052L106
—	NOVUS THERAPEUTICS INC	167,333	$2,577	2.0%	$15.40	—	COM	67011N204
—	YUMANITY THERAPEUTICS INC	108,847	$1,850	1.4%	$17.00	—	COM	98872L102
—	AFFIMED NV	219,340	$1,277	1.0%	$3.39	—	COM	N01045108
—	VISTAGEN THERAPEUTICS INC	500,000	$970	0.7%	$1.94	—	COM NEW	92840H202
—	APTEVO THERAPEUTICS INC	18,280	$670	0.5%	$36.65	—	COM NEW	03835L207
CPIX	CUMBERLAND PHARMACEUTICALS	188,703	$557	0.4%	$5.80	-47.8%	COM	230770109